A Study of Oral Recombinant Salmon Calcitonin (rsCT) to Prevent Postmenopausal Osteoporosis
Clinical trial NCT01292187 · COMPLETED
Trial details
- NCT number
- NCT01292187
- Sponsor
- Tarsa Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2012-05-01
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.